The Story of a Medical Specialist Who Puts Her Life on the Line in Conflict Zones. Driven solely by her vocation as a doctor, ...
In one of his best stories of all time, our former shooting editor kills an enormous crocodile on safari — or at least, he ...
Even gastric pains, which is a common symptom of ... options when buying snacks is to look for the Healthier Choice Symbol, which is used by the health authorities here on food packaging to ...
Matthew Nyamlori, whose journey through Kenya's educational system became a symbol of perseverance and determination for many, succumbed to gastric cancer on Monday, January 20. Nyamlori's ...
SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer
Department of General Surgery, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China Background: Gastric cancer (GC ...
Meanwhile, c2.cp.kegg.v7.4.symbols.gmt was selected as the reference gene set ... (44) demonstrated the significant impact of WBP11 on the proliferation and migration of gastric cancer cells. In our ...
Our Imfinzi bladder and gastric programs continue to advance with readouts for VOLGA, which builds on NIAGARA, the combination of enfortumab vedotin and Imfinzi plus minus Imjudo in patients with ...
REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development ...
ALX Oncology will host a webcast on January 23 to discuss updated ASPEN-06 trial data for evorpacept in gastric cancer. ALX Oncology Holdings Inc. will host a virtual event on January 23 at 1:00 p ...
Leap Therapeutics has come crashing down to earth. The biotech axed plans to advance into phase 3 in gastric cancer on the basis of midstage data, sending its stock down 60% to below $1 ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results